908 Devices Inc (MASS) Stock Price, Quote & News

Company Profile

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that ra...

Industry: Medical Devices

Sector: Healthcare

Phone: 857-254-1500

Website: 908devices.com

Address:

44 3rd Avenue, Burlington, United States

xbizo Apr. 9 at 4:34 PM

$MASS Visibility on this one is tough. $70MM revenue this year. Growth is solid, but not exciting for such low level of revenue. Maybe it doubles and reaches breakeven EBITDA by 2029? Any insights on catalysts?

0 · Reply

PatrickandFrankie Apr. 9 at 11:52 AM

$MASS 908 Devices 908 Devices According to AI: Why It Might Seem Like Sales are Limited Devices leadership recently noted they are waiting for impacts from the $150 billion appropriated for DHS and Border Patrol in the 2026 fiscal year. Replacement Cycles: Many agencies still use older technologies Strategic Pivot: The company only recently (early 2025) sold its bioprocessing business to focus 100% on the handheld defense and public safety market, which includes aggressive expansion into more DHS departments.

0 · Reply

OfficialStocktwitsUser Mar. 27 at 6:56 PM

$MASS RSI: 32.83, MACD: -0.1122 Vol: 0.24, MA20: 6.24, MA50: 6.43 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Sidoti Mar. 20 at 10:35 PM

908 Devices ($MASS) Management Team presented at the Sidoti Small-Cap Virtual Conference this week. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_rb94-xr9QPyFewc5E6MmJQ

0 · Reply

Helloa11 Mar. 3 at 2:23 PM

$MASS How how can this go today ?

0 · Reply

JasonCO Mar. 3 at 12:29 PM

$MASS ARKK average is in the $40’s

1 · Reply

StocktwitsEarnings Mar. 3 at 12:22 PM

$MASS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.11 up 119.64% YoY • Reported revenue of $17.38M down -7.65% YoY • 908 Devices expects full year 2026 revenues to be in the range of $64.5M to $67.5M, representing 15% to 20% growth compared to 2025 revenue from continuing operations.

0 · Reply

ElizabethVoorhees140 Feb. 21 at 6:48 AM

$MASS Massimo Group operates specialty manufacturing. Revenue visibility is limited. Liquidity risk remains high.

0 · Reply

OfficialStocktwitsUser Feb. 13 at 5:14 PM

$MASS RSI: 50.36, MACD: 0.1718 Vol: 0.34, MA20: 6.51, MA50: 6.05 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

lorenaw Feb. 8 at 11:24 PM

$MASS let’s go 🏈🏈🏈 !!! Good luck New England 🔥🔥🔥Patriots Superbowl LX 👏🏼👏🏼👏🏼👏🏼👏🏼👏🏼

1 · Reply

908 Devices to Present at the Sidoti Small Cap Conference

Mar 3, 2026, 7:00 AM EST - 6 weeks ago

908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook

Feb 24, 2026, 7:00 AM EST - 7 weeks ago

908 Devices to Participate in Investor Conferences in March

Feb 17, 2026, 7:00 AM EST - 2 months ago

908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Feb 5, 2026, 7:00 AM EST - 2 months ago

908 Devices Enhances MX908 Usability and Adds New Drug Targets

Jan 20, 2026, 7:00 AM EST - 3 months ago

908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

Nov 10, 2025, 7:00 AM EST - 5 months ago

908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

Oct 30, 2025, 7:00 AM EDT - 6 months ago

908 Devices to Participate in Upcoming Investor Conferences

Oct 28, 2025, 7:00 AM EDT - 6 months ago

United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification

Oct 22, 2025, 7:00 AM EDT - 6 months ago

908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 16, 2025, 7:00 AM EDT - 6 months ago

United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices

Aug 5, 2025, 7:00 AM EDT - 9 months ago

908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

Aug 4, 2025, 7:00 AM EDT - 9 months ago

908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

Jul 29, 2025, 7:00 AM EDT - 9 months ago

908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 22, 2025, 7:00 AM EDT - 9 months ago

908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 8, 2025, 7:00 AM EDT - 10 months ago

908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances

Jun 25, 2025, 8:03 AM EDT - 10 months ago

Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500

Jun 16, 2025, 8:00 AM EDT - 10 months ago

908 Devices Appoints Christopher D. Brown to its Board of Directors

RGEN

Jun 3, 2025, 7:00 AM EDT - 11 months ago

Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit

May 22, 2025, 7:00 AM EDT - 11 months ago

908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference

May 13, 2025, 7:00 AM EDT - 1 year ago

908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

Apr 30, 2025, 7:00 AM EDT - 1 year ago

908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection

Apr 22, 2025, 7:00 AM EDT - 1 year ago

908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation

Mar 11, 2025, 7:00 AM EDT - 1 year ago

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device

Mar 4, 2025, 1:26 PM EST - 1 year ago

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

RGEN

Mar 4, 2025, 7:45 AM EST - 1 year ago

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 4, 2025, 7:30 AM EST - 1 year ago

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

RGEN

Mar 3, 2025, 4:30 PM EST - 1 year ago

908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Jan 14, 2025, 4:01 PM EST - 1 year ago

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Dec 19, 2024, 7:00 AM EST - 1 year ago

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

Nov 12, 2024, 7:00 AM EST - 1 year ago

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Oct 22, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024

Sep 6, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Participate in Craig-Hallum Bioprocessing Conference

Aug 6, 2024, 7:00 AM EDT - 1 year ago

908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook

Aug 6, 2024, 7:00 AM EDT - 1 year ago

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

BCYC BSY MLI NJR OFIX QBTS SMMT

Jul 30, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference

Jul 23, 2024, 7:00 AM EDT - 1 year ago

908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 25, 2024, 7:00 AM EDT - 1 year ago

908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

Jun 18, 2024, 7:00 AM EDT - 1 year ago

908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

Apr 30, 2024, 7:45 AM EDT - 2 years ago

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Apr 30, 2024, 7:30 AM EDT - 2 years ago

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

Apr 23, 2024, 7:00 AM EDT - 2 years ago

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

Mar 12, 2024, 7:00 AM EDT - 2 years ago

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

Mar 5, 2024, 7:00 AM EST - 2 years ago

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

Feb 29, 2024, 7:00 AM EST - 2 years ago

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares' Fully Integrated Cell Therapy Manufacturing Platform

Feb 20, 2024, 7:00 AM EST - 2 years ago

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Nov 14, 2023, 7:00 AM EST - 2 years ago

908 Devices Announces MX908 Integration Capabilities

Nov 7, 2023, 7:00 AM EST - 2 years ago

908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

Nov 6, 2023, 4:30 PM EST - 2 years ago

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

Oct 24, 2023, 4:30 PM EDT - 2 years ago

908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device

xbizo Apr. 9 at 4:34 PM

0 · Reply

PatrickandFrankie Apr. 9 at 11:52 AM

0 · Reply

OfficialStocktwitsUser Mar. 27 at 6:56 PM

0 · Reply

Sidoti Mar. 20 at 10:35 PM

908 Devices ($MASS) Management Team presented at the Sidoti Small-Cap Virtual Conference this week. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_rb94-xr9QPyFewc5E6MmJQ

0 · Reply

Helloa11 Mar. 3 at 2:23 PM

$MASS How how can this go today ?

0 · Reply

JasonCO Mar. 3 at 12:29 PM

$MASS ARKK average is in the $40’s

1 · Reply

StocktwitsEarnings Mar. 3 at 12:22 PM

0 · Reply

ElizabethVoorhees140 Feb. 21 at 6:48 AM

$MASS Massimo Group operates specialty manufacturing. Revenue visibility is limited. Liquidity risk remains high.

0 · Reply

OfficialStocktwitsUser Feb. 13 at 5:14 PM

0 · Reply

lorenaw Feb. 8 at 11:24 PM

$MASS let’s go 🏈🏈🏈 !!! Good luck New England 🔥🔥🔥Patriots Superbowl LX 👏🏼👏🏼👏🏼👏🏼👏🏼👏🏼

1 · Reply

DARKP00L Feb. 5 at 12:17 PM

$MASS 07:17 on Feb. 05 2026 908 Devices Updates MX908 Mission Mode For Hazardous Vapor Sampling And Adds Five New Drug Targets Including Medetomidine #tradeideas

0 · Reply

OfficialStocktwitsUser Jan. 28 at 10:59 PM

$MASS RSI: 69.89, MACD: 0.2438 Vol: 0.67, MA20: 5.85, MA50: 5.92 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Love_To_Learn Jan. 20 at 3:38 PM

ENERGY $MAAS $MASS $WATT initiating code energy for market

0 · Reply

Godwins26 Jan. 20 at 3:02 PM

Watchlist to the moon 🚀🌕 $IVF $RILY $KEP $IBRX $MASS

0 · Reply

Godwins26 Jan. 20 at 3:01 PM

Watchlist $IVF $RILY $KEP $IBRX $MASS

0 · Reply

DARKP00L Jan. 20 at 12:16 PM

$MASS 07:14 on Jan. 20 2026 908 Devices Reports Preliminary Q4 2025 Revenue Of $17.2M And Full-Year Revenue Of $56M, With Positive Adjusted EBITDA In Q4 #tradeideas

0 · Reply

DrStonkenstein Jan. 8 at 9:36 AM

$CHOW Lazy, Incompetent, manipulative, and Dont speaaka tha Englgish .. what can anybody say about the chiity Wok.. $MASS $FUSE $HKIT

0 · Reply

OfficialStocktwitsUser Jan. 2 at 9:35 AM

$MASS RSI: 23.29, MACD: -0.3386 Vol: 0.52, MA20: 5.91, MA50: 6.52 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

DoughCook Jan. 1 at 4:27 AM

$MASS — Momentum rolled over after a failed rally. Head & Shoulders breakdown puts sellers back in control.

0 · Reply

HamletHedge Dec. 25 at 8:43 AM

$MASS Market tolerance narrows as uncertainty lingers, as investors weigh durability over pace. Measured progress can gradually rebuild conviction.

0 · Reply

SuperGreenToday Dec. 18 at 4:14 PM

$MASS Share Price: $5.54 Contract Selected: May 15, 2026 $5 Calls Buy Zone: $1.15 – $1.42 Target Zone: $2.00 – $2.45 Potential Upside: 65% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Helloa11 Nov. 11 at 9:57 PM

$MASS WTF again ? Down to below $6 from above $9 . Should have sold 50 % of it for profit.

2 · Reply

Market Cap	273.62M
Revenue (ttm)	56.20M
Net Income (ttm)	19.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	34.68%
Debt to Equity Ratio	0.00

Volume	187,800
Avg Vol	278,290
Day's Range	N/A - N/A
Shares Out	37.38M
Stochastic %K	79%
Beta	0.54
Analysts	Strong Sell
Price Target	$10.00